Is Official Ivermectin Petition Going to Spark an Expert Grass-roots Movement for Early Covid-19 Treatment in Canada?

Is Official Ivermectin Petition Going to Spark an Expert Grass-roots Movement for Early Covid-19 Treatment in Canada

Canada, as pretty much every other Western country, hasn’t narrowed down a treatment for early onset COVID-19. TrialSite News has been extensively reporting on various research pipelines for a year now. It looks like some Canadians would like to start finally using more treatment interventions as the third wave, and new “variants of concern” are spreading across the country. Hospitals are now even preparing for the possibility that patient triaging may be necessary if ICUs get overwhelmed. There are already reports that in Canada, a country where healthcare is overseen by provinces, some hospitals with full ICUs beds have to transport patients to different facilities. 

Such triage in one of the most developed countries in the world is certainly difficult for Canadians, and many are perhaps thinking about the images from overrun hospitals in Northern Italy that stunned the world last spring. The resurgence of the pandemic at such levels is scary. 

For the government agencies and many ordinary Canadians, the obvious solution is to return to extensive lockdowns and to speed up vaccination efforts. Canada’s largest province – Ontario – has become the most locked-down area in North America but that hasn’t  prevented the 3rd wave. Vaccination efforts in the country are also riddled with complications. While the AstraZeneca vaccine was originally reserved for those under 55 in Canada, the country recently suspended its use in this age group due to world-wide blood clotting concerns.

It appears that Canadians are starting to look for other solutions, and some experts may be coming to their side. TrialSiteNews recently spoke with Ondrej Halgas, a researcher at University of Toronto. Dr. Halgas is originally from Slovakia and has been actively promoting the use of early treatment, particularly with ivermectin. Back in January, we reported that this Central European country became the 1st in the EU to approve ivermectin for both prophylaxis and treatment of Covid-19. The news since then spread to the neighboring Czech Republic. Halgas recently provided us with an update but he also talked about the recent developments in Canada. 

After TrialSite’s January report, Halgas was able to get in touch with federal Canadian Member of Parliament Dean Allison who has since then shown leadership and has engaged his parliamentary colleagues about the issue. Dr. Halgas even talked to MP Allison on his program. MP Allison has recently also backed an official parliamentary petition that urges for immediate adoption and availability of ivermectin in Canada as a Covid-19 treatment option. 

The petition was initiated by a former pharmacology professor Kanji Nakatsu from Queen’s University and closes for signatures on April 24th. It is certainly very important to collect as many signatures as possible to increase its impact. Prof. Nakatsu is among a growing local group of concerned doctors, scientists and community activists that are coming together to give an official voice to early treatment and other science-based pandemic recommendations. 

They are already well-connected to US experts and groups such as the Front Line COVID-19 Critical Care Alliance (FLCCC). This is definitely needed as both the federal, as well as provincial governments, seem to be unwilling to solicit outside expert opinions.      

Country’s institutions are slow to react to the newest scientific data and their responses to concerned citizens inquiring about ivermectin and other treatment options are evasive.

It’s therefore likely that as was the case in countries like South Africa, Zimbabwe, Slovakia, Macedonia, Czech Republic and others, push for early treatment’s acceptance in Canada will have to come from bottom up. As the aforementioned countries illustrate, it’s very much possible to impact policy when people, hopefully with the support of some experts, make enough noise.

Call to Action: TrialSite will continue to watch Canadian situation closely.   Visit TrialSite Community to contribute your thoughts and ideas, with no censorship.     


This site uses Akismet to reduce spam. Learn how your comment data is processed.

  1. Does anyone have current data on the staistical trends of COVID-19 cases, hospitalizations and deaths in nations where Ivermectin is in widespread use?
    Seems to me that such real-world data would be highly illuminating, re Ivermectin’s effectiveness.

    1. 1. Not every city/state/province within a country is doing the same thing. India is a good example.
      2. The introduction of mass vaccinations are muddying the waters. We are seeing spikes in mortality right after initiation – perhaps d/t temporary lowered immunity due to vaccine during a pandemic???
      3. Some countries that adopted Ivermectin are having difficulty getting access to the drug and distributing.

      If you don’t already, follow/watch FLCCC data analyst Juan Chamie

      1. Okay, then is there ongoing data for the India states with widespread ivermectin adoption vis-a-vis non-adoption?
        I’m only interested in the data. And, it seems to me that if such data actually exists, then that would be good evidence of real-world success using ivermectin.

  2. all vaccines are temporarely approved,because there is no cure for covid-19. the moment Ivermectine is aaccepted cure for covid-19,all vaccines lose their temporary approval. big pharma will do everything to prevent that happening. And that is how it is and will be in the future. No chance. High five to corruption in the western world.

    1. You are only the short term consequences of the acceptance of Ivermectin as treatment for Covid-19. The big picture is that Ivermectin has already shown to be effective against Zika as well, so it could in theory
      be effective against any other viruses, that will be the end of the antiviral drugs business as well. Can you imagine now how much money to lose ,and how little fear can they instil into people, and how little control can they exert. They don’t want that to happen.